PALB2 and ovarian cancer: In addition, identifying the presence of recurrent and/or none PALB2 PVs/LPVs will help in understanding the contribution to breast cancer and ovarian cancer risk and tailor the best preventive and treatment option of PALB2 carriers from Middle Eastern ethnicity.